Niki BioSolutions, Inc. (NIKI) EBITDA (2024 - 2025)
Niki BioSolutions' (NIKI) quarterly EBITDA came in at -$361283.0 in Q4 2025, down 336.79% YoY from $152574.6 in Q4 2024, and up 37.14% on a QoQ basis from -$574699.0 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) EBITDA (2024 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 2 years of EBITDA data on file, last reported at -$361283.0 in Q4 2025.
- Quarterly EBITDA fell 336.79% year-over-year to -$361283.0 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $170237.0 (changed N/A YoY) and the FY2025 annual result came in at -$643250.0, down 42.5% from the prior year.
- EBITDA improved to -$361283.0 in Q4 2025, from -$574699.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $1.2 million in Q2 2025 to a low of -$574699.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | -361,283.00 |
| Aug 31, 2025 | -574,699.00 |
| May 31, 2025 | 1.19 Mn |
| Nov 30, 2024 | -82,713.00 |
| Aug 31, 2024 | -150,079.00 |